Calcium Channel, Voltage-Dependent, P/Q Type, Alpha-1A Subunit

Alternative Names

  • CACNA1A
  • Calcium Channel, L Type, Alpha-1 Polypeptide, Isoform 4
  • CACNL1A4
  • CaV2.1
  • CACNA1A C-Terminal Polypeptide
  • Alpha-1A C-Terminal Polypeptide
  • ALPHA-1ACT
Back to search Result
OMIM Number

601011

NCBI Gene ID

773

Uniprot ID

O00555

Length

426,584 bases

No. of Exons

49

No. of isoforms

6

Protein Name

Voltage-dependent P/Q-type calcium channel subunit alpha-1A

Molecular Mass

282564 Da

Amino Acid Count

2506

Genomic Location

chr19:13,206,442-13,633,025

Gene Map Locus
19p13.13

Description

Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [From RefSeq]

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_000068.4:c.997A>GLebanonchr19:13335891Likely PathogenicDevelopmental and Epileptic Encephalopathy 42NG_011569.1:g.175570A>G; NM_000068.4:c.997A>G; NP_000059.3:p.Asn333Asp
NM_001127221.1:c.4991G>ALebanonchr19:13235693Likely Pathogenic, Pathogenic, Uncertain SignificanceLikely PathogenicDevelopmental and Epileptic Encephalopathy 42NG_011569.1:g.275768G>A; NM_001127221.1:c.4991G>A; NP_001120693.1:p.Arg1664Gln12190824768432
NM_001127222.2:c.1030ATC[2]United Arab EmiratesNC_000019.10:g.13335858_13335860delPathogenicLikely PathogenicDevelopmental and Epileptic Encephalopathy 42NG_011569.1:g.175609_175609del; NM_001127222.2:c.1030ATC[2]; NP_000059.3:p.Ile346del2058556589972987
© CAGS 2024. All rights reserved.